Aspire BioPharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | |||
EBITDA | -1,453 | -15,651 | -8,638 | -242 |
EBIT | -799 | -15,556 | -11,075 | -242 |
Net Income | -1,981 | -15,941 | -11,966 | -243 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,140 | -1,751 | 479 | -533 |
Cash | 206 | 1,346 | 3 | 16 |
Basic Shares | 49,333 | 7,765 | 7,765 | 45,937 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | 0 | 0 | |
EBITDA | -11,645 | -358 | -596 |
EBIT | -1,210 | -358 | -596 |
Net Income | -12,537 | -359 | -597 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -265 | 11 | -5,038 |
Cash | 3 | 11 | |
Basic Shares | 8,244 | 45,937 | 45,937 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.04 |
2025-03-31 | -$0.42 |
2024-12-31 | -$1.15 |
2024-09-30 | -$0.06 |
